Publications by authors named "Nandkumar Kadam"

Claim this Profile
H
Hydroxychloroquine an Antimalarial Drug, Exhibits Potent Antifungal Efficacy Against Candida albicans Through Multitargeting.
Sargun Tushar Basrani, Tanjila Chandsaheb Gavandi, Shivani Balasaheb Patil, Nandkumar Subhash Kadam, Dhairyasheel Vasantrao Yadav

J Microbiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.
Mariette Barbier, Katherine S Lee, Mayur S Vikharankar, Shriram N Rajpathak, Nandkumar Kadam

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in -Mutated Lung Cancer.
Vanita Noronha, Vijay Maruti Patil, Amit Joshi, Nandini Menon, Anuradha Chougule, Nandkumar Kadam

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer.
Vanita Noronha, Arvind Sahu, Vijay M Patil, Amit Joshi, Anant Ramaswamy, Nandkumar Kadam

South Asian J Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curative intent therapy in oligometastatic lung cancer with an unresectable primary with N3 nodes: case report and review of the literature.
Vanita Noronha, Amit Joshi, Vijay M Patil, Sunny Jandyal, Neha Mittal, Nandkumar Kadam

Lung Cancer Manag· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis